What is the role of amylin as an emerging therapeutic agent in obesity?
Abstract
Gut hormone analogues have become the cornerstone of pharmacotherapy against obesity. Most prominent are the incretin analogues mimicking the actions of glucagon-like-peptide 1 (GLP-1) and glucose-...
Fields of Study & Subjects
Adipokines
Inflammation
and Metabolic Diseases
Peroxisome Proliferator-Activated Receptors
Genetics
Aging
and Longevity in Model Organisms
Publication details
- Journal / source
- Expert Review of Endocrinology & Metabolism
- Publisher
- Informa UK Limited
- Volume
- 21
- Issue
- 4
- Pages
- 245–248
- Publication date
- 30 April 2026
- Language
- EN